Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease - PubMed (original) (raw)

Review

. 2016 May;61(5):1246-67.

doi: 10.1007/s10620-016-4040-6. Epub 2016 Jan 25.

Affiliations

Free article

Review

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

Alessandro Mantovani et al. Dig Dis Sci. 2016 May.

Free article

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many developed countries, affecting an estimated 30 % of the adult population. In this updated clinical review, we summarize the current knowledge regarding the strong association between NAFLD and the risk of coronary heart disease (CHD) and other functional, structural, and arrhythmic cardiac complications (e.g., left ventricular dysfunction, heart valve diseases and atrial fibrillation). We also briefly discuss the putative biological mechanisms linking NAFLD with these important extra-hepatic complications. To date, a large body of evidence has suggested that NAFLD is not simply a marker of CHD and other functional, structural, and arrhythmic cardiac complications, but also may play a part in the development and progression of these cardiac complications. The clinical implication of these findings is that patients with NAFLD may benefit from more intensive surveillance and early treatment interventions aimed at decreasing the risk of CHD and other cardiac and arrhythmic complications.

Keywords: Cardiac arrhythmias; Cardiac disease; Cardiovascular disease; Heart valve diseases; Myocardial dysfunction; Nonalcoholic fatty liver disease.

PubMed Disclaimer

References

    1. Curr Cardiol Rep. 2014 Nov;16(11):540 - PubMed
    1. N Engl J Med. 2010 Sep 30;363(14 ):1341-50 - PubMed
    1. Atherosclerosis. 2007 Apr;191(2):391-6 - PubMed
    1. BMJ Open. 2014 Mar 20;4(3):e004973 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1855-60 - PubMed

Publication types

MeSH terms

LinkOut - more resources